Treatment of childhood kaposiform hemangioendothelioma with sirolimus.
about
Tuberous Sclerosis Complex Associated with Vascular Anomalies or Overgrowth.Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.Mediastinal kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in a patient with no skin changes and a normal chest CT.Vascular tumours in infants. Part II: vascular tumours of intermediate malignancy [corrected] and malignant tumours.Successful treatment of Kaposiform hemangioendothelioma with everolimus.Refractory Kasabach-Merritt phenomenon successfully treated with sirolimus, and a mini-review of the published work.Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon.Kasabach-Merritt phenomenon in Chinese children: Report of 19 cases and brief review of literatureRole of Sirolimus in Advanced Kaposiform Hemangioendothelioma.Exome sequence analysis of Kaposiform hemangioendothelioma: identification of putative driver mutationsMedical therapy for pediatric vascular anomaliesTreatment of cystic hygroma in a young infant through multidisciplinary approach involving sirolimus, sclerotherapy, and debulking surgerySirolimus for treatment of kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon.Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomalies.Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.Vascular anomaly cases for the pediatric hematologist oncologists-An interdisciplinary review.Angiopoietins as serum biomarkers for lymphatic anomalies.Combined blockade of AKT/mTOR pathway inhibits growth of human hemangioma via downregulation of proliferating cell nuclear antigen.Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone.Refractory Kaposiform Hemangioendothelioma Associated with the Chromosomal Translocation t(13;16)(q14;p13.3).Sirolimus for Vincristine-Resistant Kasabach-Merritt Phenomenon: Report of Eight Patients.Blue Rubber Bleb Nevus Syndrome: Promising Response To Sirolimus.Sirolimus therapy in the treatment of pseudomyogenic hemangioendothelioma.Sirolimus therapy for children with problematic kaposiform haemangioendothelioma and tufted angioma.Clinical observations in mesh suture treatment for infants of Kasabach-Merritt phenomenon.Impact of sirolimus treatment for refractory kaposiform hemangioendothelioma with exacerbation of the disease 10 years after initial diagnosis.Successful Management of Kaposiform Hemangioendothelioma with Long-Term Sirolimus Treatment: a Case Report and Review of the Literature.Musculoskeletal complication in kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon: clinical characteristics and management
P2860
Q30248734-6D203D9D-82D1-4B45-8522-A56553C9531AQ33401519-90BF5EE0-DDF4-4006-B443-D0D795EC49D8Q33407224-5F9F3910-02FF-4579-B3CC-F6590A6AF953Q33410429-167D4840-F91D-4F83-B386-EF309DB566E4Q33416117-247366E2-2BFF-44D1-BE74-7E34A2487A03Q33418149-DB815A6C-6836-4F82-AC14-E916228BB1EFQ33420786-827DDE3B-1CA7-4764-9464-9B532E469B5EQ33423967-372D5082-6CD7-435C-8FE9-08D6C2C0663BQ33425445-49026238-A08D-4F3D-BCF1-266D0A4CA1C9Q33429915-5999A467-0AE4-4578-AC93-3C850578F850Q33438540-B5942903-98F8-4327-A5B4-4091312DD1FCQ33832551-C69C671E-E218-4F99-8268-5DB285ECBF8AQ37223197-1B85650B-56B9-4383-9516-30E33CCC36C8Q37490783-E24F750B-3F9B-44B1-82C3-6133722AAEB6Q38958282-46DBB169-467B-4C0A-98BB-768051DA6613Q39155894-64414135-9CCF-42E4-922B-A64070F46C26Q39447507-BDCE43ED-F4D7-4F6C-8D41-BB73A599E7B8Q40418897-31969D06-A1B7-469D-905A-C5968942CF11Q44297831-80C274A4-F21C-49EE-9C82-8E487B384DC8Q44729102-591AC5AD-C349-41DF-9DDB-9C2C6626FCE1Q46043799-A86F5669-FF49-4BA7-8C54-D575CE0B0759Q47438107-079E0C0D-E1C4-4E97-B793-4D2AF6D12E92Q47875057-90A198E6-6EFA-4DD1-90BE-C4478404E37CQ47902471-70D77B02-DC78-443E-A9D2-CF3844F41F99Q48172746-30580FCC-D64E-4691-927B-FD66693FAE43Q50458453-1E26AC85-ACF7-4127-A4A3-08210148FF3FQ54941077-8174DE71-DFF5-4412-8EAC-504CA73F15A5Q55539095-4533AC70-15AA-4D39-AA3C-89D3D6605A84Q58759095-3E26D714-6346-405B-A91C-EC0F97F5AD23
P2860
Treatment of childhood kaposiform hemangioendothelioma with sirolimus.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Treatment of childhood kaposiform hemangioendothelioma with sirolimus.
@en
Treatment of childhood kaposiform hemangioendothelioma with sirolimus.
@nl
type
label
Treatment of childhood kaposiform hemangioendothelioma with sirolimus.
@en
Treatment of childhood kaposiform hemangioendothelioma with sirolimus.
@nl
prefLabel
Treatment of childhood kaposiform hemangioendothelioma with sirolimus.
@en
Treatment of childhood kaposiform hemangioendothelioma with sirolimus.
@nl
P2093
P356
P1476
Treatment of childhood kaposiform hemangioendothelioma with sirolimus.
@en
P2093
Billie Moats-Staats
Dean S Morrell
John Woosley
Joseph Stavas
Julie Blatt
P304
P356
10.1002/PBC.22766
P577
2010-12-01T00:00:00Z